Down-regulation of proinflammatory capacity during apoptosis in human polymorphonuclear leukocytes

被引:92
作者
Kobayashi, SD [1 ]
Voyich, JM [1 ]
Braughton, KR [1 ]
DeLeo, FR [1 ]
机构
[1] NIAID, Lab Human Bacterial Pathogenesis, Rocky Mt Labs, NIH, Hamilton, MT 59840 USA
关键词
D O I
10.4049/jimmunol.170.6.3357
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Polymorphonuclear leukocytes (PMNs) are essential to innate immunity in humans and contribute significantly to inflammation. Although progress has been made, the molecular basis for termination of inflammation in humans is incompletely characterized. We used human oligonucleotide microarrays to identify genes encoding inflammatory mediators that were differentially regulated during the induction of apoptosis. One hundred thirty-three of 212 differentially expressed genes encoding proinflammatory factors, signal transduction mediators, adhesion molecules, and other proteins that facilitate the inflammatory response were down-regulated during the-induction of apoptosis following PMN phagocytosis. Among these, 42 genes encoded proteins critical to the inflammatory response, including receptors for IL-8beta, IL-10alpha, IL-13alpha1, IL-15alpha, IL-17, IL-18, C1q, low-density lipoprotein, IgG Fc (CD32), and formyl peptide, Toll-like receptor 6, platelet/endothelial cell adhesion molecule-1 (CD31), P-selectin (CD62), IL-1alpha, IL-16, and granulocyte chemoattractant protein-2 were down-regulated. Many of these genes were similarly down-regulated during Fas-mediated or camptothecin-induced apoptosis. We used flow cytometry to confirm that IL-8Rbeta (CXCR2) and IL-1a were significantly down-regulated during PMN apoptosis. We also discovered that 23 genes encoding phosphoinositide and calcium-mediated signal transduction components, which comprise complex pathways essential to the inflammatory response of host cells, were differentially regulated during PMN apoptosis. Importantly, our data demonstrate that PMNs down-regulate proinflammatory capacity at the level of gene expression during induction of apoptosis. These findings provide new insight into the molecular events that resolve inflammation following PMN activation in humans.
引用
收藏
页码:3357 / 3368
页数:12
相关论文
共 48 条
  • [1] Functional expression of IL-9 receptor by human neutrophils from asthmatic donors: Role in IL-8 release
    Abdelilah, SG
    Latifa, K
    Esra, N
    Cameron, L
    Bouchaib, L
    Nicolaides, NC
    Levitt, RC
    Hamid, Q
    [J]. JOURNAL OF IMMUNOLOGY, 2001, 166 (04) : 2768 - 2774
  • [2] The CXC chemokines growth-regulated oncogene (GRO) alpha, GRO beta, GRO gamma, neutrophil-activating peptide-2, and epithelial cell-derived neutrophil-activating peptide-78 are potent agonists for the type B, but not the type A, human interleukin-8 receptor
    Ahuja, SK
    Murphy, PM
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (34) : 20545 - 20550
  • [3] BAGGIOLINI M, 1994, ADV IMMUNOL, V55, P97
  • [4] Human chemokines: An update
    Baggiolini, M
    Dewald, B
    Moser, B
    [J]. ANNUAL REVIEW OF IMMUNOLOGY, 1997, 15 : 675 - 705
  • [5] The versatility and universality of calcium signalling
    Berridge, MJ
    Lipp, P
    Bootman, MD
    [J]. NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2000, 1 (01) : 11 - 21
  • [6] Boyum A, 1968, Scand J Clin Lab Invest Suppl, V97, P77
  • [7] Akt promotes cell survival by phosphorylating and inhibiting a forkhead transcription factor
    Brunet, A
    Bonni, A
    Zigmond, MJ
    Lin, MZ
    Juo, P
    Hu, LS
    Anderson, MJ
    Arden, KC
    Blenis, J
    Greenberg, ME
    [J]. CELL, 1999, 96 (06) : 857 - 868
  • [8] THE PRODUCTION OF CYTOKINES BY POLYMORPHONUCLEAR NEUTROPHILS
    CASSATELLA, MA
    [J]. IMMUNOLOGY TODAY, 1995, 16 (01): : 21 - 26
  • [9] COLOTTA F, 1994, J BIOL CHEM, V269, P12403
  • [10] Up-regulation of IL-10R1 expression is required to render human neutrophils fully responsive to IL-10
    Crepaldi, L
    Gasperini, S
    Lapinet, JA
    Calzetti, F
    Pinardi, C
    Liu, Y
    Zurawski, S
    de Waal Malefyt, R
    Moore, KW
    Cassatella, MA
    [J]. JOURNAL OF IMMUNOLOGY, 2001, 167 (04) : 2312 - 2322